Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
January 30, 2018
Patent Application Number
14987432
Date Filed
January 4, 2016
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present invention provides glycan-interacting antibodies and methods for producing glycan-interacting antibodies useful in the treatment and prevention of human disease, including cancer. Such glycan-interacting antibodies include monoclonal antibodies, derivatives, and fragments thereof as well as compositions and kits comprising them. Further provided are methods of using glycan-interacting antibodies to target cells and treat disease.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
